Market Place
Sourcing Support
Click Cuts Staff After Commercial Deal Restructuring
14 Apr 2026 //
FIERCE BIOTECH
Click Therapeutics Cuts 27% Of Workforce After $50M Raise
13 Apr 2026 //
ENDPOINTS NEWS
Click Therapeutics, Boehringer Ingelheim Secure Series D
09 Apr 2026 //
GLOBENEWSWIRE
Ultrahuman & Click Partner for FDA-Cleared Migraine Biomarker
14 Jan 2026 //
GLOBENEWSWIRE
Dassault Systèmes Invests In Click Therapeutics
19 Mar 2025 //
BUSINESSWIRE
Click Therapeutics CEO Named To 2024 PharmaVoice 100 List
08 Oct 2024 //
BUSINESSWIRE
Click Therapeutics Announces CT-132 Met Endpoint for Migraine Reduction
04 Sep 2024 //
BUSINESSWIRE
Click buys Better assets to speed its digital obesity drive
23 May 2024 //
PHARMAPHORUM
Click Acquires Better Therapeutics For Obesity Expansion
22 May 2024 //
BUSINESSWIRE
FDA clears Otsuka, Click`s prescription app for depression
03 Apr 2024 //
FIERCE BIOTECH
Otsuka and Click Thera Announce the FDA Clearance of Rejoyn for the MDD Symptoms
01 Apr 2024 //
BUSINESSWIRE
Click Therapeutics and BI Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic
04 Jan 2024 //
BUSINESSWIRE
Click, Indivior to make digital therapeutics for addiction
08 Sep 2023 //
FIERCE BIOTECH
Click Therapeutics Announces Participation in Investor Events
03 Aug 2023 //
BUSINESSWIRE
Click Therapeutics & BI Pivotal Trial of Prescription Digital Therapeutics
04 May 2023 //
BUSINESSWIRE
Boehringer Ingelheim to trial Click`s digital schizophrenia app
04 May 2023 //
FIERCE BIOTECH
Click Therapeutics to Present at 22nd Annual Needham Healthcare Conference
13 Apr 2023 //
BUSINESSWIRE
Click Therapeutics Shares 2022 Accomplishments and Development Progress
23 Dec 2022 //
BUSINESSWIRE
Boehringer deepens collaboration with Click Therapeutics in a deal of $460M
19 Dec 2022 //
ENDPTS
Click Therapeutics nets FDA breakthrough nod for migraine app
19 Dec 2022 //
FIERCEBIOTECH
Boehringer deepens collaboration with Click Therapeutics in a deal of $460M
19 Dec 2022 //
ENDPTS
Click Therapeutics nets FDA breakthrough nod for migraine app
19 Dec 2022 //
FIERCEBIOTECH
Click Receives FDA Breakthrough Device Designation for Prescription Digital
16 Dec 2022 //
BUSINESSWIRE
Click Therapeutics Announces Participation in Upcoming Investor Conferences
11 Nov 2022 //
BUSINESSWIRE
Click Therapeutics Announces Participation in Upcoming Investor Conferences
14 Sep 2022 //
BUSINESSWIRE
Click Therapeutics to Present at the Canaccord Genuity Conference
05 Aug 2022 //
BUSINESSWIRE
Click Therapeutics to Present at the Jefferies Healthcare Conference
02 Jun 2022 //
BUSINESSWIRE
Click Therapeutics to Present at the UBS Global Healthcare Conference
19 May 2022 //
BUSINESSWIRE
Click Tx to Present at Chardan’s Prescription Digital Therapeutics Summit
07 Apr 2022 //
BUSINESSWIRE
Click Therapeutics Announces Formation of Scientific Advisory Board
28 Mar 2022 //
BUSINESSWIRE
Altoida, Click Tx Partner to Power Trials with Digital Cognitive Assessment
24 Feb 2022 //
BUSINESSWIRE
Sanofi joins $52M series B for digital therapeutics maker Click
23 Oct 2021 //
FIERCEBIOTECH
Otsuka, Click enlist Verily for digital depression app study
25 Feb 2021 //
FIERCE BIOTECH
Otsuka & Click Therapeutics Initiate First-of-its-Kind Fully Remote Trial
24 Feb 2021 //
BUSINESSWIRE
